21.961 articles found

1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease

NAGATO SATOSHI, UENO KOHSHI, KAWANO KOKI, NORIMINE YOSHIHIKO, ITO KOICHI, HANADA TAKAHISA, UENO MASATAKA, AMINO HIROYUKI, OGO MAKOTO, HATAKEYAMA SHINJI, URAWA YOSHIO, NAKA HIROYUKI, GROOM ANTHONY JOHN, RIVERS LEANNE, SMITH TERENCE.

· 2001-06-08

BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE

NORCROSS ROGER DAVID, ALANINE ALEXANDER, FLOHR ALEXANDER, RIEMER CLAUS, MILLER AUBRY KERN.

· 2001-06-08

BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE

ALANINE ALEXANDER, FLOHR ALEXANDER, MILLER AUBRY KERN, NORCROSS ROGER DAVID, RIEMER CLAUS.

· 2001-06-08

Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.

Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia A.

Ther Drug Monit · 2001-06-01

DOI: 10.1097/00007691-200106000-00007PMID: 11360029

Therapy and management of frontal lobe dementia patients.

Litvan I.

Neurology · 2001-06-01

DOI: 10.1212/wnl.56.suppl_4.s41PMID: 11402150

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

Olanow CW, Watts RL, Koller WC.

Neurology · 2001-06-01

DOI: 10.1212/wnl.56.suppl_5.s1PMID: 11402154

Acute and chronic haloperidol treatments increase parkin mRNA levels in the rat brain.

Nakahara T, Gotoh L, Motomura K, Kawanami N, Ohta E, Hirano M, Uchimura H.

Neurosci Lett · 2001-06-01

DOI: 10.1016/s0304-3940(01)01880-8PMID: 11403966

Response to levodopa treatment in dopa-responsive dystonia.

Nutt JG, Nygaard TG.

Arch Neurol · 2001-06-01

DOI: 10.1001/archneur.58.6.905PMID: 11405805

Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

Cranston RE.

Neurology · 2001-06-01

DOI: 10.1212/wnl.56.12.1782-aPMID: 11425962

[Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease].

Högl B, Wetter TC, Trenkwalder C.

Nervenarzt · 2001-06-01

DOI: 10.1007/s001150050773PMID: 11433700

By the way, doctor... My father has Parkinson's disease, and it seems to be getting worse. He's having a harder and harder time getting around. His memory has slipped badly. I've read about fetal-cell therapy for Parkinson's, but then heard on the news that it doesn't work--and might even make some people worse. What do you think?

Lee TH.

Harv Health Lett · 2001-06-01

PMID: 11439271

Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease.

Najib J.

Clin Ther · 2001-06-01

DOI: 10.1016/s0149-2918(01)80071-0PMID: 11440283